# Reviva Pharmaceuticals Holdings, Inc.: Form SCHEDULE 13D/A, filed Dec 20, 2024

- Company: [Reviva Pharmaceuticals Holdings, Inc.](/companies/rvph.md) (CIK 1742927)
- Form: SCHEDULE 13D/A
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 16:30 ET
- Period: not reported
- Accession: 0001437749-24-038128
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924038128/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1742927/000143774924038128/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1742927/000143774924038128/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-038128. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.